|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 262, Issue 6 1106-R1110, Copyright © 1992 by American Physiological Society
ARTICLES |
S. Okada, D. A. York and G. A. Bray
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808.
The effect of mifepristone (RU 486), a blocker of type II glucocorticoid receptors on the development of obesity that follows the feeding of a high-fat (HF) diet to Osborne-Mendel (OM) rats, has been investigated. OM rats fed a HF diet gained more weight and had larger retroperitoneal and parametrial fat pads than OM rats fed a high-carbohydrate low-fat (LF) diet. RU 486 (30 mg.kg-1.day-1) for 14 days completely reversed the body weight gain and the increase in fat pad size of OM rats fed a HF diet. RU 486 had no effect on body weight of OM rats fed a LF diet, but did reduce fat pad weights. The data suggest that type II glucocorticoid receptor activity modulates body fat deposition and is essential for the development of obesity, although a minor role for progestin receptor activity cannot be ruled out.
This article has been cited by other articles:
![]() |
X. Tang, A. R. Chander, and L. P. Schramm Sympathetic activity and the underlying action potentials in sympathetic nerves: a simulation Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2003; 285(6): R1504 - R1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Makimura, T. M. Mizuno, H. Bergen, and C. V. Mobbs Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1266 - E1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Bartness, G. E. Demas, and C. K. Song Seasonal Changes in Adiposity: the Roles of the Photoperiod, Melatonin and Other Hormones, and Sympathetic Nervous System Experimental Biology and Medicine, June 1, 2002; 227(6): 363 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Whorwood, S. J. Donovan, D. Flanagan, D. I.W. Phillips, and C. D. Byrne Increased Glucocorticoid Receptor Expression in Human Skeletal Muscle Cells May Contribute to the Pathogenesis of the Metabolic Syndrome Diabetes, April 1, 2002; 51(4): 1066 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fitzgerald, J. R. Henegar, M. W. Brands, L. K. Henegar, and J. E. Hall Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R547 - R552. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mantha, E. Palacios, and Y. Deshaies Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R455 - R464. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lin, M. R. Chavez, R. C. Bruch, G. E. Kilroy, L. A. Simmons, L. Lin,, H. D. Braymer, G. A. Bray, and D. A. York The Effects of a High Fat Diet on Leptin mRNA, Serum Leptin and the Response to Leptin Are Not Altered in a Rat Strain Susceptible to High Fat Diet-Induced Obesity J. Nutr., October 1, 1998; 128(10): 1606 - 1613. [Abstract] [Full Text] |
||||
![]() |
J. E. Friedman, Y. Sun, T. Ishizuka, C. J. Farrell, S. E. McCormack, L. M. Herron, P. Hakimi, P. Lechner, and J. S. Yun Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription and Hyperglycemia Are Regulated by Glucocorticoids in Genetically Obese db/db Transgenic Mice J. Biol. Chem., December 12, 1997; 272(50): 31475 - 31481. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Clapham and N. C. Turner Effects of the Glucocorticoid II Receptor Antagonist Mifepristone on Hypertension in the Obese Zucker Rat J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1503 - 1508. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |